<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">85862</article-id><article-id pub-id-type="doi">10.7554/eLife.85862</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cancer Biology</subject></subj-group></article-categories><title-group><article-title>A novel triptolide analog downregulates NF-kB and induces mitochondrial apoptosis pathways in human pancreatic cancer</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-302060"><name><surname>Tian</surname><given-names>Qiaomu</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4267-7362</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-306631"><name><surname>Zhang</surname><given-names>Peng</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-306632"><name><surname>Wang</surname><given-names>Yihan</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-306633"><name><surname>Si</surname><given-names>Youhui</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-306634"><name><surname>Yin</surname><given-names>Dengping</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-283942"><name><surname>Weber</surname><given-names>Christopher R</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-143439"><name><surname>Fishel</surname><given-names>Melissa L</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-294232"><name><surname>Pollok</surname><given-names>Karen E</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-306635"><name><surname>Qiu</surname><given-names>Bo</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-306636"><name><surname>Xiao</surname><given-names>Fei</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf4"/></contrib><contrib contrib-type="author" corresp="yes" id="author-306503"><name><surname>Chong</surname><given-names>Anita S</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0460-0196</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Department of Surgery</institution>, <institution>University of Chicago</institution>, <addr-line><named-content content-type="city">Chicago</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution>Cinkate Pharmaceutical Corp</institution>, <addr-line><named-content content-type="city">Shanghai</named-content></addr-line>, <country>China</country></aff><aff id="aff3"><institution content-type="dept">Department of Pathology</institution>, <institution>University of Chicago</institution>, <addr-line><named-content content-type="city">Chicago</named-content></addr-line>, <country>United States</country></aff><aff id="aff4"><institution content-type="dept">Department of Pediatrics</institution>, <institution>Indiana University</institution>, <addr-line><named-content content-type="city">indianapolis</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-238838"><name><surname>El-Deiry</surname><given-names>Wafik S</given-names></name><role>Reviewing editor</role><aff><institution>Brown University</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>achong@uchicago.edu</email> (AC);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>25</day><month>10</month><year>2023</year></pub-date><volume>12</volume><elocation-id>e85862</elocation-id><history><date date-type="received"><day>29</day><month>12</month><year>2022</year></date><date date-type="accepted"><day>24</day><month>10</month><year>2023</year></date></history><permissions><copyright-statement>© 2023, Tian et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Tian et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-85862-v1.pdf"/><abstract><p>Pancreatic cancer is the seventh leading cause of cancer-related death worldwide, and despite advancements in disease management, the 5-year survival rate stands at only 12%. Triptolides have potent anti-tumor activity against different types of cancers, including pancreatic cancer, however poor solubility and toxicity limit their translation into clinical use. We synthesized a novel pro-drug of triptolide, (<italic>E</italic>)-19-[(1'-benzoyloxy-1'-phenyl)-methylidene]-Triptolide (CK21), which was formulated into an emulsion for in vitro and in vivo testing in rats and mice, and using human pancreatic cancer cell lines and patient-derived pancreatic tumor organoids. A time-course transcriptomic profiling of tumor organoids treated with CK21 in vitro was conducted to define its mechanism of action, as well as transcriptomic profiling at a single time point post-CK21 administration in vivo. Intravenous administration of emulsified CK21 resulted in the stable release of triptolide, and potent anti-proliferative effects on human pancreatic cancer cell lines and patient-derived pancreatic tumor organoids <italic>in vitro,</italic> and with minimal toxicity <italic>in vivo</italic>. Time course transcriptomic profiling of tumor organoids treated with CK21 <italic>in vitro</italic> revealed &lt;10 differentially expressed genes (DEGs) at 3 h and ~8,000 DEGs at 12 h. Overall inhibition of general RNA transcription was observed, and Ingenuity pathway analysis together with functional cellular assays confirmed inhibition of the NF-κB pathway, increased oxidative phosphorylation and mitochondrial dysfunction, leading ultimately to increased reactive oxygen species (ROS) production, reduced B-cell-lymphoma protein 2 (BCL2) expression, and mitochondrial-mediated tumor cell apoptosis. CK21 is a novel pro-drug of triptolide that exerts potent anti-proliferative effects on human pancreatic tumors by inhibiting the NF-κB pathway, leading ultimately to mitochondrial-mediated tumor cell apoptosis.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution>Cinkate Pharmaceutical Corp</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Chong</surname><given-names>Anita S</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Peng Zhang, was an employee of Cinkate Pharmaceutical Corp. Is listed as an inventor on Patent WO2018/019301A1, which covers the design and use of CK21 for pancreatic cancer..</p></fn><fn fn-type="conflict" id="conf3"><p>Bo Qiu, was an employee of Cinkate Pharmaceutical Corp..</p></fn><fn fn-type="conflict" id="conf4"><p>Fei Xiao, is listed as an inventor on Patent WO2018/019301A1, which covers the design and use of CK21 for pancreatic cancer..</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: All animal experiments were approved by the Institutional Animal Care and Use Committee at the University of Chicago, and adhered to the standards of the NIH Guide for the Care and Use of Laboratory Animals. Pancreatic tumors from patients with pancreatic ductal adenocarcinoma were collected under University of Chicago IRB12-1108 and IRB13-1149.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>Sequencing data have been deposited in GEO under Accession code GSE225011</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Tian Q</collab><collab>Chong A</collab></person-group><year iso-8601-date="2023">2023</year><source>Triptolide analogs induced apoptosis on pancreatic cancer patient-derived organoids</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE225011">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE225011</ext-link><comment>NCBI Gene Expression Omnibus, GSE225011</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-85862-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>